Deferral of FDA consideration of enforcement discretion
MKTUPDTE
Wed, Aug 10 2022 09:48 am
The a2 Milk Company (a2MC, the Company) wishes to advise that earlier today it received notification from the US Food and Drug Administration (FDA) that, at this time, the FDA is deferring further consideration of the Company’s request for enforcement discretion to import infant milk formula (IMF) products into the US.
The Company has also subsequently been advised by the International Dairy Foods Association (IDFA) that equivalent letters have been sent to all pending enforcement discretion applicants, indicating that the FDA is deferring any further review at this time of all pending applications.
Authorised for release by
David Bortolussi
Managing Director and Chief Executive Officer
The a2 Milk Company Limited
Announcement PDF
Markets News
Markets
Fletcher dodges product recall in upbeat end to August for NZX 50
The S&P/NZX 50 Index rose 97.07 points, or 0.8%, to 12,447.68.
Markets
Fletcher Building expects $168m hit from leaky pipes response
Fletcher Building subsidiary Iplex Australia to cover 80% of repair costs.
Markets
Ritchies posts $17m annual net loss
The bus operator's net loss widened from $8m to $17m in the year to March 31.
